Event

Elgar Concert Hall
event_note Friday, 11 Oct 2019
query_builder 14:45 - 15:30
card_travel Panel Discussion
mic English
Clinical research is one of the most expensive areas of drug development and bringing a drug to market can take up to 13 years and involve a huge amount of capital investment.

Setting up to do a first in man trial places many demands on a small company, particularly those companies where many of the personnel are scaling a steep learning curve.  Not only do you have to think about your preclinical work, source appropriate quality materials for your trial but also design the trial, identify appropriate partners and receive the necessary approval from the regulators.  There’s plenty of scope for wasting money and time – something you or your investors will be keen to avoid.

To keep costs low, maximise competitive advantage, and deliver life-saving therapies to patients as quickly as possible, the life Sciences industry must leverage novel management models, new technologies and creative study approaches to accelerate clinical trials.

Our expert panel will discuss these and other relevant issues pertaining to successful Clinical Trials Including:
  • Top tips for successful clinical development
  • Adapting your work practices to comply with GLP and getting ready for GCP
  • Sourcing clinical grade materials – when is GMP appropriate and identifying credible suppliers
  • Designing your trial to maximise your asset’s value
  • Selecting clinical development partners - boutique, multinational behemoth, therapeutically focused - or even no CRO at all, and how best to work with them
  • Difficulties in recruiting volunteers and enrolling them in a study
  • Contract and budget negotiations with investigative sites
  • Country selection and initiation, regulatory compliance, and standardising procedures – the pros and cons of conducting studies in in emerging markets
Speakers
Helen Underwood
Director, Strategic Client Relationships
Thermo Fisher Scientific
star star star star star
Bryan Deane
New Medicines & Data Policy Director
Association of the British Pharmaceutical Industry (ABPI)
star star star star star
Richard Fitzgerald
Director
The Royal Liverpool and Broadgreen University Hospitals NHS Trust
star star star star star
Adam Wood
General Manager, Europe
myClin - Clinical Oversight Platform
star star star star star
Liz Allen
Vice President Early Clinical Development
IQVIA
star star star star star
Processing. Please wait.
Loading...